Onycholysis
- May 2022
- 10min
Therapeutic classes inducing this adverse event
Chemotherapy, EGFR inhibitor, MEK inhibitor, mTOR inhibitor
CTCAE V5.0
Asymptomatic separation of the nail bed from the nail plate or nail loss
SIMPLIFIED GRADING
Asymptomatic
References
Peuvrel L, Cassecuel J, Bernier C, Quéreux G, Saint-Jean M, Le Moigne M, Frénard C, Khammari A, Dréno B; Supported by GESTIM Nantes group of cutaneous adverse events induced by cancer treatments. TOXICAN: a guide for grading dermatological adverse events of cancer treatments. Support Care Cancer. 2018;26:2871-7.
CTCAE V5.0
Symptomatic separation of the nail bed from the nail plate or nail loss; limiting instrumental ADL
SIMPLIFIED GRADING
Symptomatic OR Limiting instrumental ADL
References
Peuvrel L, Cassecuel J, Bernier C, Quéreux G, Saint-Jean M, Le Moigne M, Frénard C, Khammari A, Dréno B; Supported by GESTIM Nantes group of cutaneous adverse events induced by cancer treatments. TOXICAN: a guide for grading dermatological adverse events of cancer treatments. Support Care Cancer. 2018;26:2871-7.
Browse for more adverse events